A novel dna vaccine constructed by heat shock protein 70 and melanoma antigen-encoding gene 3 against tumorigenesis

Indian Journal of Experimental Biology

Volumn 48, Issue 5, 2010, Pages 436-443

  Qu, Ping ^a,b   Ma, Jia Hai ^a,b   Zhang, Xiu Min ^b,c   Huang, Xiao Jun ^a,b   Yang, Xin Wei ^b,c   Sui, Yan Fang ^b,c  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b YANTAI YUHUANGDING HOSPITAL   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antitumor agents; Heat shock proteins 70; MAGE 3 protein; Recombinant DNA vaccines

Indexed keywords

BACTERIAL PROTEIN; CANCER ANTIBODY; CANCER VACCINE; DNA VACCINE; GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; HSP70 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; HYBRID PROTEIN; MAGEA3 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR PROTEIN;

ACTIVE IMMUNIZATION; ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; COMPARATIVE STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG SCREENING; EXPERIMENTAL MELANOMA; GENETICS; HUMAN; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; SECRETION; MELANOMA, EXPERIMENTAL; SECRETION (PROCESS);

ANIMALS; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; BACTERIAL PROTEINS; CANCER VACCINES; CYTOTOXICITY, IMMUNOLOGIC; DRUG SCREENING ASSAYS, ANTITUMOR; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOTHERAPY, ACTIVE; INJECTIONS, INTRAMUSCULAR; INTERFERON-GAMMA; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 77954305630     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ma J H, Sui Y F, Ye J, Huang Y Y, Li Z S, Chen G S, Qu P, Song H P & Zhang X M, Heat shock protein 70/MAGE-3 fusion protein vaccine can enhance cellular and humoral immune responses to MAGE-3 in vivo, Cancer Immunol Immunother, 54 (2005) 907.
2. Leitner W W, Ying H & Restifo N P, DNA and RNA-based vaccines: principles, progress and prospects, Vaccine, 18 (1999) 765.
3. Carpentier A F, Rosenfeld M R, Delattre J Y, Whalen R G, Posner J B & Dalmau J, DNA vaccination with HuD inhibits growth of a neuroblastoma in mice, Clin Cancer Res, 4 (1998) 2819.
4. Kim J J, Yang J S, Manson K H & Weiner D B, Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants, Vaccine, 19 (2001) 2496.
5. Zhu M, Xu X, Liu H, Liu X, Wang S, Dong F, Yang B & Song G, Enhancement of DNA vaccine potency against herpes simplex virus 1 by co-administration of an interleukin-18 expression plasmid as a genetic adjuvant, J Med Microbiol, 52 (2003) 223.
6. Kim T W, Hung C F, Ling M, Juang J, He L, Hardwick J M, Kumar S & Wu T C, Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins, J Clin Invest, 112 (2003) 109.
7. You Z, Huang X, Hester J, Toh H C & Chen S Y, Targeting dendritic cells to enhance DNA vaccine potency, Cancer Res, 61 (2001) 3704.
8. Kim T W, Hung C F, Boyd D, Juang J, He L, Kim J W, Hardwick J M & Wu T C, Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies, J Immunol, 171 (2003) 2970.
9. Park J H, Kim C J, Lee J H, Shin S H, Chung G H & Jang Y S, Effective immunotherapy of cancer by DNA vaccination, Mol Cells, 9 (1999) 384.
10. Bueler H & Mulligan R C, Induction of antigen-specific tumor immunity by genetic and cellular vaccines against MAGE: Enhanced tumor protection by coexpression of granulocyte-macrophage colony-stimulating factor and B7-1, Mol Med, 2 (1996) 545.
11. Hsu K F, Hung C F, Cheng W F, He L, Slater L A, Ling M & Wu T C, Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen, Gene Ther, 8 (2001) 376.
12. Chen C H, Wang T L, Hung C F, Yang Y, Young R A, Pardoll D M & Wu T C, Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene, Cancer Res, 60 (2000) 1035.
13. Ye J, Chen G S, Song H P, Li Z S, Huang Y Y, Qu P, Sun Y J, Zhang X M & Sui Y F, Heat shock protein 70/MAGE-1 tumor vaccine can enhance the potency of MAGE-1-specific cellular immune responses in vivo, Cancer Immunol Immunother, 53 (2004) 825.
14. Donnelly J J, Ulmer J B & Liu M A, Immunization with DNA, J Immunol Methods, 176 (1994) 145.
15. Li Y, Subjeck J, Yang G, Repasky E & Wang X Y, Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy, Vaccine, 24 (2006) 5360.
16. Li H, Ou X & Xiong J, Modified HPV16 E7/HSP70 DNA vaccine with high safety and enhanced cellular immunity represses murine lung metastatic tumors with downregulated expression of MHC class I molecules, Gynecol Oncol, 104 (2007) 564.
17. Banchereau J & Steinman R M, Dendritic cells and the control of immunity, Nature, 392 (1998) 245.
18. Castellino F, Boucher P E, Eichelberg K, Mayhew M, Rothman J E, Houghton A N & Germain R N, Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways, J Exp Med, 191 (2000) 1957.
19. Arnold-Schild D, Hanau D, Spehner D, Schmid C, Rammensee H G, de la Salle H & Schild H, Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells, J Immunol, 162 (1999) 3757.
20. Norbury C C, Chambers B J, Prescott A R, Ljunggren H G & Watts C, Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells, Eur J Immunol, 27 (1997) 280.
21. Steinman R M, The dendritic cell system and its role in immunogenicity, Annu Rev Immunol, 9 (1991) 271.
22. Corr M, Lee D J, Carson D A & Tighe H, Gene vaccination with naked plasmid DNA: Mechanism of CTL priming, J Exp Med, 184 (1996) 1555.
23. Basu S, Binder R J, Ramalingam T & Srivastava P K, CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin, Immunity, 14 (2001) 303.
24. Berard F, Blanco P, Davoust J, Neidhart-Berard E M, Nouri-Shirazi M, Taquet N, Rimoldi D, Cerottini J C, Banchereau J & Palucka A K, Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells, J Exp Med, 192 (2000) 1535.
25. Jeannin P, Renno T, Goetsch L, Miconnet I, Aubry J P, Delneste Y, Herbault N, Baussant T, Magistrelli G, Soulas C, Romero P, Cerottini J C & Bonnefoy J Y, OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway, Nat Immunol, 1 (2000) 502.
26. Underhill D M, Ozinsky A, Hajjar A M, Stevens A, Wilson C B, Bassetti M & Aderem A, The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens, Nature, 401 (1999) 811.
27. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I & Banchereau J, Activation of human dendritic cells through CD40 cross-linking, J Exp Med, 180 (1994) 1263.
28. Qazi K R, Wikman M, Vasconcelos N M, Berzins K, Stahl S & Fernandez C, Enhancement of DNA vaccine potency by linkage of Plasmodium falciparum malarial antigen gene fused with a fragment of HSP70 gene, Vaccine, 23 (2005) 1114.
29. Todryk S, Melcher A A, Hardwick N, Linardakis E, Bateman A, Colombo M P, Stoppacciaro A & Vile R G, Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake, J Immunol, 163 (1999) 1398.
30. Quaglino E, Iezzi M, Mastini C, Amici A, Pericle F, Di Carlo E, Pupa S M, De Giovanni C, Spadaro M, Curcio C, Lollini P L, Musiani P, Forni G & Cavallo F, Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice, Cancer Res, 64 (2004) 2858.